IPIX.US Innovation Pharmaceuticals Inc

Healthcare Biotechnology USA Stocks
0.0005 USD
Close of Nov 14, 2026
Market cap
USD 259K
P/E
-
P/B
1.78x
ROE
-302.9%
Dividend yield
33.18%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2023.

Is IPIX.US undervalued?

Graham number

The Graham number of Innovation Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Innovation Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Innovation Pharmaceuticals Inc yet.

Innovation Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Innovation Pharmaceuticals Inc

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It offers Brilacidin, a immunomodulatory drug candidate with anti-inflammatory and antimicrobial therapeutic applications. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorpor…

Full company profile